Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-24

FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved the supplemental application from Sun Pharmaceutical for ipratropium bromide and albuterol sulfate, enabling the generic inhalation combination pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (ipratropium bromide and albuterol sulfate)

Snippet

SUPPL AP for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)